Concurrent radiofrequency ablation and Nissen fundoplication

Résumé fourni par la source

Endoscopic radiofrequency ablation (RFA) today represents a well-established, safe and effective procedure for the treatment of Barrett’s esophagus (BE). Choice of additional treatment to RFA emerges as an important clinical issue, due to the fact that recurrence of BE after complete eradication (CE) of intestinal metaplasia (IM) or dysplasia may occur. Concerning the data available so far, recurrence may occur due to insufficient reflux control with standard PPI’s regimen, while those with large hiatal hernia and long segment BE represent the subgroup of patients at highest risk for recurrence. Due to the anatomical deviation in distal esophageal segment proper ablation may be difficult in such patients. These patients can be treated by employing concurrent ARS and RFA. Concurrent ARS and RFA was proven to be safe, not time consuming, and it can be performed in conjunction with the basic rules of RFA procedure. Early results, in term of enhanced healing of treated epithelium, and possible reduction in number of ablation sessions needed to achieve CE of IM or dysplasia, are promising. To conclude, antireflux surgery may have important role in some patients undergoing RFA, especially those with significant hiatal hernia and anatomical impairment in distal esophageal segment.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.